Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)

Clinical trial NCT04267913 · WITHDRAWN

Trial details

NCT number: NCT04267913
Sponsor: SWOG Cancer Research Network
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Squamous Cell Carcinoma Recurrent Lung Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8

Start date: 2020-09-05
Primary completion: 2025-10-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.